
Targeting the PDGF-B/PDGFR-β Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-ββ Signaling and Attenuate Liver Fibrosis
Keywords: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BDL, bile duct ligation; EGFR, epidermal growth factor receptor; FBS, fetal bovine serum; FLT3, FMS-like tyrosine kinase 3; HBV, hepatitis B virus; HAS, human serum albumin; HSC, hepatic stel